Skip to main content
SpringerLink
Log in
Book cover

Treatment of Urolithiasis pp 37–59Cite as

Urolithiasis—Patient Evaluation and Medical Treatment

  • Conference paper

  • 132 Accesses

Part of the book series: Recent Advances in Endourology ((ENDOUROLOGY,volume 3))

Summary

The surgical management of urinary stone disease has evolved in the last three decades from traditional open surgery to minimally invasive techniques including extracorporeal shock wave lithotripsy. ureteroscopy, and percutaneous surgery. Although similar dramatic advances in the medical treatment of urolithiasis have not occurred, much progress has been made in understanding factors that are important in the genesis and prevention of urinary calculi.

This chapter aims to provide a current practical set of guidelines for the assessment and medical management of patients with urolithiasis, based on the latest available information regarding pathogenesis and medical treatment options. All urolithiasis patients should undergo a basic evaluation, which is considered to be the minimal essential diagnostic workup, in order to rule out obvious, treatable systemic causes of urinary stone disease. Stone analysis, when available, should be an indispensable part of the assessment in order to identify specific types of urinary stones and allow the application of the most appropriate medical therapy. Every patient should be advised about conservative nonspecific preventative measures. High-risk calcium stone patients should have a more extensive metabolic evaluation based on two 24-h urine samples.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Consensus conference (1988) Prevention and treatment of kidney JAMA 260: 977–981

    Google Scholar 

  2. Levy FL. Adams-Huet, Pak CYC (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98: 50–59

    Article  PubMed  CAS  Google Scholar 

  3. Marangella M, Vitale C. Bagnis C, Bruno M. Ramello A (1999) Idiopathic calcium nephrolithiasis. Nephron 81 (Suppl 1): 38–44

    Article  PubMed  CAS  Google Scholar 

  4. Clark JY, Thompson IM, Optenberg SA (1995) Economic impact of urolithiasis in the United States. J Urol 154: 2020–2024

    Article  PubMed  CAS  Google Scholar 

  5. Parks JH, Coe FL (1996) Pathogenesis and treatment of calcium stones. Semin Nephrol 16: 398–411

    PubMed  CAS  Google Scholar 

  6. Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50: 1706–1712

    Article  PubMed  CAS  Google Scholar 

  7. Tomson CRV (1995) Prevention of recurrent calcium stones: a rational approach. Br J Urol 76: 419–424

    Article  PubMed  CAS  Google Scholar 

  8. Williams RE (1963) Long-term survey of 538 patients with upper urinary tract stone. Br J Urol 35: 416

    Article  PubMed  CAS  Google Scholar 

  9. Borghi L, Meschi T, Guerra A, Noverini A (1993) Randomized prospective study of a nonthiazide diuretic, Indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22 (Suppl 6): S78 — S86

    PubMed  Google Scholar 

  10. Lingeman JE (1983) Nephrolithiasis: a controllable disease. Indiana Med 17: 313

    Google Scholar 

  11. Parks JH, Coward M, Coe FL (1997) Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51: 894–900

    Article  PubMed  CAS  Google Scholar 

  12. Fleisch H (1978) Inhibitors and promoters of stone formation. Kidney Int 13: 361–371

    Article  PubMed  CAS  Google Scholar 

  13. Melnick I, Landes RR, Hoffman AA, Burch JF (1971) Magnesium therapy for recurring calcium oxalate urinary calculi. J Urol 105: 119–122

    PubMed  CAS  Google Scholar 

  14. Pak CYC, Sakhaee K, Fuller CJ (1983) Physiological and physiochemical prevention of calcium-stone formation by potassium citrate therapy. Trans Assoc Am Phys 96: 294–305

    PubMed  CAS  Google Scholar 

  15. Hess B, Nakagawa Y, Parks JH, Coe FL (1991) Molecular abnormality of TammHorsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 260: F569 — F578

    PubMed  CAS  Google Scholar 

  16. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR (1998) Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53: 194–199

    Article  PubMed  CAS  Google Scholar 

  17. Asplin J, Deganello S, Nakagawa YN, Coe FL (1991) Evidence that nephrocalcin inhibits nucleation of calcium oxalate monohydrate crystals. Am J Physiol 261: F824–F830

    PubMed  CAS  Google Scholar 

  18. Doyle IR, Marshall VR, Dawson CJ, Ryall RL (1995) Calcium oxalate crystal matrix extract: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro. Urol Res 23: 53–62

    Article  PubMed  CAS  Google Scholar 

  19. Atmani F, Khan SR (1995) Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine. Urol Res 23: 95–101

    Article  PubMed  CAS  Google Scholar 

  20. Cao LC, Boeve ER, de Bruijn WC, Kok DJ. de Water R, Deng G, Schroder FH (1997) Glycosaminoglycans and semi-synthetic sulfated polysaccharides: an overview of their potential application in treatment of patients with urolithiasis. Urology 50: 173–183

    Article  PubMed  CAS  Google Scholar 

  21. Pillay S, Asplin JR, Coe FL (1998) Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol 275: F255 — F261

    PubMed  CAS  Google Scholar 

  22. McDonald MW, Stoller M (1997) Urinary stone disease: a practical guide to metabolic evaluation. Geriatrics 52 (5): 38–40

    PubMed  CAS  Google Scholar 

  23. Tiselius HG (1994) Investigation of single and recurrent stone formers. Miner Electrolyte Metab 20: 321–327

    PubMed  CAS  Google Scholar 

  24. Kohan AD, Armenakas NA, Fracchia JA (1999) Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus. J Urol 161: 1765–1768

    Article  PubMed  CAS  Google Scholar 

  25. Cohen TD, Ehreth J, King LR. Preminger GM (1996) Pediatric urolithiasis: medical and surgical management. Urology 47:292–303

    Google Scholar 

  26. Cryer PE, Garber AJ, Joffsten P (1975) Renal failure after small intestinal bypass for obesity. Arch Intern Med 135: 1610–1612

    Article  PubMed  CAS  Google Scholar 

  27. Gigax JH, Leach JR (1971) Uric acid calculi associated with ileostomy for ulcerative colitis. J Urol 105: 777–779

    PubMed  CAS  Google Scholar 

  28. Dobbins JW. Binder HJ (1976) Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70: 1096–1100

    PubMed  CAS  Google Scholar 

  29. Mostafavi MR. Ernst RD, Saltzman B (1998) Accurate determination of chemical composition of urinary calculi by spiral computerized tomography. J Urol 159: 673–675

    Article  PubMed  CAS  Google Scholar 

  30. Saw KC. McAteer JA. Monga A. Chua GT, Lingeman JE. Williams JC (2000) Helical CT of urinary calculi: Effect of stone composition, stone size, and scan collimation. Am J Roentgenol 175: 329–332

    Google Scholar 

  31. Pak CYC (1982) Should patients with single renal stone occurrence undergo diagnostic evaluation? J Urol 127: 855–858

    PubMed  CAS  Google Scholar 

  32. Preminger GM (1989) The metabolic evaluation of patients with recurrent nephrolithiasis: a review of comprehensive and simplified approaches. J Urol 141: 760–763

    PubMed  CAS  Google Scholar 

  33. Tiselius HG (1994) Investigation of single and recurrent stone formers. Miner Electrolyte Metab 20: 321–327

    PubMed  CAS  Google Scholar 

  34. Strauss AL, Coe FL, Parks JH (1982) Formation of a single calcium stone of renal origin: clinical and laboratory characteristics of patients. Arch Intern Med 142: 504507

    Google Scholar 

  35. Preminger GM (1995) Medical management of urinary calculus disease. Part 1. Pathogenesis and evaluation. AUA Update Ser 14: 38

    Google Scholar 

  36. Werness PG, Brown CM, Smith LH, Finlayson B (1985) Equi12: a basic computer program for the calculation of urinary saturation. J Urol 134: 1242–1244

    PubMed  CAS  Google Scholar 

  37. Tiselius HG (1997) Metabolic evaluation of patients with stone disease. Urol Int 59: 131–141

    Article  PubMed  CAS  Google Scholar 

  38. Yagisawa T, Chandhoke PS, Fan J (1999) Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161: 1449–1452

    Article  PubMed  CAS  Google Scholar 

  39. Pak CYC, Ohata M. Lawrence EC, Snyder W (1974) The hypercalciurias: courses, parathyroid functions and idiopathic criteria. J Clin Invest 54: 387–400

    Article  PubMed  CAS  Google Scholar 

  40. Asplin JR, Favus MJ. Coe FL (1996) Nephrolithiasis. In: Brenner BM (ed) Brenner and Rector’s The Kidney. 5th edn. Saunders, Philadelphia, pp 1893–1935

    Google Scholar 

  41. Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327: 1141–1152

    Article  PubMed  CAS  Google Scholar 

  42. Coe FL, Parks JH (1977) New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res 12: 522

    Article  Google Scholar 

  43. Preminger GM (1995) Medical management of urinary calculus disease. Part II. Classification of metabolic disorders and selective medical treatment. AUA Update Ser 14: 38

    Google Scholar 

  44. Frank M, de Vries A, Tikva P (1966) Prevention of urolithiasis. Arch Environ Health 13: 625–630

    PubMed  CAS  Google Scholar 

  45. Borghi L, Meschi T, Schianchi T, Briganti A, Guerra A, Allegri F. Novarini A (1999) Urine volume: stone risk factor and preventive measure. Nephron 81 (Suppl 1): 31–37

    Article  PubMed  CAS  Google Scholar 

  46. Curhan GC, Willett WC, Rimm EB, Stampeer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 12: 833–838

    Article  Google Scholar 

  47. Wabner CL, Pak CYC (1993) Effect of orange juice consumption on urinary stone risk factors. J Urol 149: 1405–1408

    PubMed  CAS  Google Scholar 

  48. Goldfarb DS, Coe FL (1999) Beverages, diet and prevention of kidney stones. Am J Kidney Dis 33: 398–400

    Article  PubMed  CAS  Google Scholar 

  49. Bataille P, Pruna A, Gregoire I (1983) Critical role of oxalate restriction in association with calcium restriction to decrease the probability of being a stone former: insufficient effect in idiopathic hypercalciuria. Proc Eur Dial Transplant Assoc 20: 401–406

    PubMed  CAS  Google Scholar 

  50. Coe FL, Parks JH, Favus MJ (1997) Diet and calcium: the end of an era? Ann Intern Med 126: 553–555

    PubMed  CAS  Google Scholar 

  51. Trinchieri A, Nespoli R, Ostini F, Rovera F, Zanetti G, Pisani E (1998) A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 159: 654–657

    Article  PubMed  CAS  Google Scholar 

  52. Leonetti F. Dussol B, Berthezene P, Thirion X, Berland Y (1998) Dietary and urinary risk factors for stones in idiopathic calcium stone formers compared with healthy subjects. Nephrol Dial Trans 13: 617

    Article  CAS  Google Scholar 

  53. Silver J, Rubinger D, Friedlaender MM, Popovtzer MM (1983) Sodium-dependent idiopathic hypercalciuria in renal stone formers. Lancet 2: 484–486

    Article  PubMed  CAS  Google Scholar 

  54. Ruml LA, Pearle MS, Pak CYC (1997) Medical therapy calcium oxalate urolithiasis. Urol Clin North Am 24: 117–133

    Article  PubMed  CAS  Google Scholar 

  55. Massey LK, Sutton RA (1993) Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones. J Am Diet Assoc 93: 1305–1307

    Article  PubMed  CAS  Google Scholar 

  56. Parivar F, Low RK, Stoller ML (1996) The influence of diet on urinary stone disease. J Urol 155: 432–440

    Article  PubMed  CAS  Google Scholar 

  57. Breslau NA, Brinkley L, Hill K, Pak CYC (1988) Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrin Metab 66: 140

    Article  CAS  Google Scholar 

  58. Wilson DM (1989) Clinical and laboratory approaches for evaluation of nephrolithiasis. J Urol 141: 770–774

    PubMed  CAS  Google Scholar 

  59. Hosking DH, Erickson SB, Van Den Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130: 1115–1118

    PubMed  CAS  Google Scholar 

  60. Pak CY (1999) Medical prevention of renal stones. Nephron 81 (Suppl 1): 60–65

    Article  PubMed  CAS  Google Scholar 

  61. Pak CYC (1997) Southwestern internal medicine conference: medical management of nephrolithiasis—a new, simplified approach for general practice. Am J Med Sci 313: 215–219

    Article  PubMed  CAS  Google Scholar 

  62. Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculus recurrence but magnesium hydroxide does not. J Urol 139: 679–684

    PubMed  CAS  Google Scholar 

  63. Backman U, Danielson BG, Johansson G, Ljughall S, Wikstrom B (1980) Treatment of recurrent calcium stone formation with cellulose phosphate. J Urol 123: 9–13

    PubMed  CAS  Google Scholar 

  64. Insogna KL, Ellison AS, Burtis WJ, Sartori L, Lang RL, Broadus AE (1989) Trichloromethiazide and oral phosphate in patients with absorptive hypercalciuria. J Urol 141: 269–274

    PubMed  CAS  Google Scholar 

  65. Ettinger B (1976) Recurrent nephrolithiasis: natural history and effect of phosphate therapy. Am J Med 61: 200–206

    Article  PubMed  CAS  Google Scholar 

  66. Seftel A, Resnick MI (1990) Metabolic evaluation of urolithiasis. Urol Clin North Am 17: 159–169

    PubMed  CAS  Google Scholar 

  67. Coe FL (1991) Commentary: Allopurinol treatment of uric-acid disorders in calcium-stone formers. J Lithotr Stone Dis 3: 272

    Google Scholar 

  68. Ettinger B. Tang A. Citron JT et al. (1986) Randomized trial of Allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315: 1386–1389

    Article  PubMed  CAS  Google Scholar 

  69. Cochat P (1999) Primary hyperoxaluria type I. KI 55: 2533

    CAS  Google Scholar 

  70. Toussaint C (1998) Pyridoxine-responsive PH1: treatment. J Nephrol 11 (Suppl 1): 49–50

    PubMed  Google Scholar 

  71. Bushinsky DA (1998) Nephrolithiasis. J Am Soc Nephrol 9: 917–924

    PubMed  CAS  Google Scholar 

  72. Dobbins JW, Binder HJ (1977) Importance of colon in enteric hyperoxaluria. N Engl J Med 296: 298–301

    Article  PubMed  CAS  Google Scholar 

  73. Earnest DL, Gausher S. Admirand WH (1976) Treatment of enteric hyperoxaluria with calcium aluminum. Gastroenterology 70: 881A

    Google Scholar 

  74. Barcelo P, Wuhl O. Servitge E. Rousaud A, Pak CYC (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150: 1761–1764

    PubMed  CAS  Google Scholar 

  75. Lee YH, Huang WC, Tsai JY et al. (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161: 1453–1457

    Article  PubMed  CAS  Google Scholar 

  76. Dretler SP (1998) The physiologic approach to the medical management of stone disease. Urol Clin North Am 25: 613–623

    Article  PubMed  CAS  Google Scholar 

  77. Lee YH, Huang WC, Tsai JY et al. (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161: 1453–1457

    Article  PubMed  CAS  Google Scholar 

  78. Gitomer WL, Pak CYC (1996) Recent advances in the biochemical and molecular biological basis of cystinuria. J Urol 156: 1907–1912

    Article  PubMed  CAS  Google Scholar 

  79. Gupta M, Bolton DM, Stoller ML (1995) Etiology and management of cystine lithiasis. Urology 45: 344–355

    Article  PubMed  CAS  Google Scholar 

  80. Rutchik SD, Resnick MI (1997) Cystine calculi. Urol Clin North Am 24: 163–171

    Article  PubMed  CAS  Google Scholar 

  81. Norman RIM. Manette WA (1990) Dietary restriction of sodium as a means of reducing urinary cystine. J Urol 143: 1193–1195

    PubMed  CAS  Google Scholar 

  82. Chow GK, Streem SB (1996) Medical treatment of cystinuria: results of contemporary clinical practice. J Urol 156: 1576–1578

    Article  PubMed  CAS  Google Scholar 

  83. Lingeman JE, Segel YL Steele B (1995) Metabolic evaluation of infected renal lithiasis: clinical relevance. J Endourol 9: 51–54

    Article  PubMed  CAS  Google Scholar 

  84. Wang LP, Wong HY, Griffith DP (1997) Treatment options in struvite stones. Urol Clin North Am 21: 149–162

    Article  Google Scholar 

  85. Rodman JS (1999) Struvite stones. Nephron 81 (Suppl 1): 50–59

    Article  PubMed  CAS  Google Scholar 

  86. Wall I, Tiselius HG (1990) Long-term acidification of urine in patients treated for infected renal stones. Urol Int 45: 336–341

    Article  PubMed  CAS  Google Scholar 

  87. Lutzeyer W. Hering F (1986) Drug therapy of urinary calculi and prevention of recurrence. In: Schneider HJ (ed) Urolithiasis. Springer, Berlin, pp 34–41

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Methodist Hospital Institute for Kidney Stone Disease, 1801 North Senate Blvd., Suite 220, Indianapolis, IN, 46202, USA

    David A. Lifshitz & James E. Lingeman

  2. Department of Urology, Indiana University School of Medicine, USA

    Arieh L. Shalhav

Authors
  1. David A. Lifshitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arieh L. Shalhav
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James E. Lingeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Nippon Medical School, 1-1-5 Sendagi, 113-8603, Bunkyo-ku, Tokyo, Japan

    Masao Akimoto M.D. (Professor and Chairman) (Professor and Chairman)

  2. Department of Urology, Kyorin University, 6-20-2 Shinkawa, 181-8611, Mitaka, Tokyo, Japan

    Eiji Higashihara M.D. (Professor) (Professor)

  3. Department of Urology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, 700-8558, Okayama, Japan

    Hiromi Kumon M.D. (Professor) (Professor)

  4. Department of Urology, Saga Medical School, 5-1-1 Nabeshima, 849-8501, Saga, Japan

    Zenjiro Masaki M.D. (Professor) (Professor)

  5. Department of Urology, Tohoku University, 1-1 Seiryo-machi, 980-8574, Aoba-ku, Sendai, Japan

    Seiichi Orikasa M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 The Japanese Society of Endourology and ESWL

About this paper

Cite this paper

Lifshitz, D.A., Shalhav, A.L., Lingeman, J.E. (2001). Urolithiasis—Patient Evaluation and Medical Treatment. In: Akimoto, M., Higashihara, E., Kumon, H., Masaki, Z., Orikasa, S. (eds) Treatment of Urolithiasis. Recent Advances in Endourology, vol 3. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68517-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68517-3_4

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68519-7

  • Online ISBN: 978-4-431-68517-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation